Rapport Therapeutics, Inc. ($RAPP)
Filing Information
| Accession Number | 0001193125-26-037529 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 4, 2026 |
| Document Date | Feb 2, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
132,000
Total Value
$0.00
P&L
+inf% (+$3,574,560.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Feb 2, 2026 | Grant/Award | 132,000 | $0.00 | $0.00 | 132,000 | Direct | โ | View Details |